The meta-analysis by Freemantle et al noted that trials employing agents with sympathomimetic activity showed a trend toward decreased benefit.
← all excerpts
Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it "ok" to discontinue?
1
—
—